RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > A Historical Perspective on Regulation of In Vitro Diagnostics

A Historical Perspective on Regulation of In Vitro Diagnostics

Posted 01 May 2011 | By Robert Schiff, PhD, RAC, CQA, FRAPS

In vitro diagnostics, commonly referred to as IVDs, have been regulated for many years by the US Food And Drug Administration (FDA), its precursors and related government bodies. Prior to the establishment of the Medical Device Amendments of 1976, there were few federal requirements for manufacturing and sale of IVDs although some did exist and will not be discussed here.

 

© 2022 Regulatory Affairs Professionals Society.